MDAI Stock Analysis: Buy, Sell, or Hold?
MDAI - Spectral AI, Inc. Class A Common Stock
$1.68
-0.04 (-2.33%)
▼
5d:
-10.16%
30d:
-8.2%
90d:
-2.89%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When MDAI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called MDAI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MDAI is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MDAI is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDAI is currently trading at $1.68, which is considered oversold relative to its 30-day fair value range of $1.70 to $1.84.
Technical Outlook: Technically, MDAI is in a uptrend. The price is currently testing key support at $1.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.42 (+222.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDAI is in a uptrend. The price is currently testing key support at $1.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.42 (+222.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.70 -
$1.84
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 222.4% below Wall St target ($5.42)
- WARNING: Recommendation downgraded due to -10.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.70 -
$1.84
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.81
Resistance Level
$2.51
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.79
Wall Street Target
$5.42
(+222.4%)
Revenue Growth (YoY)
-40.5%
Profit Margin
-82.0%
Share & Embed Analysis
Last updated: July 14, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
Data refreshes hourly during market hours. Next update: 3:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDAI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 67 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |